Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT

Fig. 4

Evolution in serum sMR concentrations from 5 days before until matching day. Repeated measures ANOVA were done with double square root transformed data. P-values showed no difference in the evolution of sMR concentration in the three studied groups when assessing from 5 (p = 0.89), 4 (p = 0.44), 3 (p = 0.15) or 2 (p = 0.37) days before matching day until the matching day. Matching day refers to the day of antimicrobial initiation for patients with a new infection and matched ICU day for patients without a new infection. The horizontal yellow-shaded area represents the interquartile range of the sMR concentration in 59 matched healthy controls

Back to article page